Adverse Event Reporting News - Lilly adds strong warning label to Zyprexa
Wednesday, January 7th, 2009 Lilly added strong warnings to the label of Zyprexa, its best-selling medicine for schizophrenia, Oct. 5, citing the drug’s tendency to cause weight gain, high blood sugar, high cholesterol and other metabolic problems.
For the first time, Zyprexa’s label now acknowledges that …
